Japan Organ Preservation Market to Reach US$ 4.9 Million by 2032, Impelled by the Increasing Demand for Organ Transplantation

According to the latest report by IMARC Group, titled “Japan Organ Preservation Market Report by Preservation Solution (UW Solution, Custodiol HTK, Perfadex, and Others), Organ Donation Type (Living Organ Donation, Deceased Organ Donation), Technique (Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidney, Liver, Lung, Heart, and Others), End-User (Hospitals and Clinics, Organ Banks, and Others), and Region 2024-2032,” the Japan organ preservation market size reached US$ 2.9 Million in 2023. Organ preservation is the process of preserving organs outside the body for transplantation or research purposes. It employs specialized techniques to maintain the viability and functionality of organs until they can be transplanted into a recipient or utilized for scientific investigation. The preservation techniques aim to slow down the metabolic processes within the organ and reduce damage caused by lack of oxygen and nutrients. The specific preservation methods depend on the type of organ being preserved but generally involve cooling the organ, using specialized solutions, and minimizing the effects of ischemia (lack of blood flow) and reperfusion injury (damage caused by the return of blood flow). Organ preservation is a crucial component in transplantation medicine, facilitating the transportation of organs over significant distances and expanding the availability of viable organs for transplantation purposes. It is also utilized in advancing research and development (R&D) within regenerative medicine and organ transplantation domains.

Japan Organ Preservation Market Trends:

The increasing demand for organ preservation due to the growing incidences of organ transplantation and the demand for effective organ preservation methods to enhance organ viability, increase transplant success rates, and expand the pool of available organs are major factors driving the market growth. Moreover, the ongoing advancements in organ preservation techniques, including machine perfusion and cold storage methods, have led to increased organ availability, reduced organ wastage, and improved transplant outcomes, which is creating a positive outlook for the market growth. Additionally, the increasing demand for organ preservation techniques owing to the implementation of the Japanese government's initiatives and support for organ transplantation and healthcare aimed at promoting organ donation, improving transplant infrastructure, and funding research and development (R&D) efforts is contributing to the market growth. Furthermore, the increasing utilization of organ preservation techniques for regenerative medicine, including the development of tissue engineering and organ regeneration technologies, is positively impacting the market growth. In addition to this, rapid technological advancements in organ preservation, such as the development of portable preservation devices, novel preservation solutions, and improved perfusion techniques that offer efficient and effective ways of preserving organs, improving their viability, and extending the preservation time, are providing remunerative growth opportunities. In line with this, the growing popularity of Japan's organ preservation owing to the government's increased healthcare expenditure and increasing focus on investing in advanced organ preservation technologies and services is anticipated to drive the market growth. Looking forward, the market value is projected to reach US$ 4.9 Million by 2032, expanding at a CAGR of 5.94% during 2024-2032.

Market Summary:

• Based on preservation solution, the market has been divided into UW solution, custodiol HTK, perfadex and others.
• On the basis of organ donation type, the market has been bifurcated into living organ donation and deceased organ donation.
• Based on the technique, the market has been categorized into static cold storage technique, hypothermic machine perfusion, normothermic machine perfusion and others.
• On the basis of organ type, the market has been segmented into kidney, liver, lung, heart and others.
• Based on the end-user, the market has been divided into hospitals and clinics, organ banks and others.
• Region-wise, the market has been segmented into Kanto, Kinki, Central/ Chubu, Kyushu-Okinawa, Tohoku, Chugoku, Hokkaido, Shikoku.
• The competitive landscape of the market has also been examined along with the profiles of the key players.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800